|Day Low/High||4.42 / 4.53|
|52 Wk Low/High||2.79 / 5.00|
Company Will Host Investor Conference Call on Wednesday, August 19, 2015
ChromaDex Has Reported Four Consecutive Quarters of Record Net Revenue and Receives Accolades for Top Growth Company in the $10-$50 Million Annual Sales Category
The New Dietary Supplement Protects Against Oxidative Stress and Promotes Healthy Aging
ChromaDex Will Use Proprietary Suntava(R) Purple Corn to Produce a Highly Concentrated Anthocyanin Ingredient at a Price Point That Should Appeal to Mass Markets
- Total Q1 Revenue Grew 71% to $5.3 Million as Company Reports 4th Consecutive Quarter of Record Net Revenue -
Company Will Release First Quarter Earnings Report After Market Close on May 14th
ChromaDex Holds Exclusive Worldwide Patent Rights Related to Pharmaceutical and Cosmetic Preparations of Pterostilbene for Topical Application
The top 10 open-market insider purchases and sales filed at the SEC Thursday.
Standard & Poor’s announced today that it has commenced Factual Stock Report coverage on ChromaDex Corporation.
DiscoveryBioMed, Inc. (DBM) today announced that it has been awarded a $200,000 Small Business Innovations Research (SBIR) Phase 1 grant by the National Institutes of Health (NIH) to continue research into the ...
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.